COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL)

Historical Holders from Q2 2015 to Q3 2025

Symbol
COLL on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
31.6M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
37M
Holdings value
$1.29B
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
240
Number of buys
125
Number of sells
-110
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15.6% $134M 5M BlackRock, Inc. 31 Mar 2025
Rubric Capital Management LP 9.34% +29.3% $80.3M $17.4M 3M +27.7% Rubric Capital Management LP 31 Mar 2025
RENAISSANCE TECHNOLOGIES LLC 5.06% +4.8% $56M $2.73M 1.6M +5.13% Renaissance Technologies LLC 08 Sep 2025
Invesco Ltd. 4.9% -10% $48.1M -$5.79M 1.58M -10.7% Invesco Ltd. 30 Jun 2025
PRINCIPAL GLOBAL INVESTORS 4.6% $44.5M 1.47M PRINCIPAL GLOBAL INVESTORS 30 Jun 2025
Pacer Advisors, Inc. 1.06% -86.8% $11.2M -$46.2M 419K -80.4% Pacer Advisors, Inc. 31 Mar 2025

Institutional Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 37M $1.29B +$41.3M $34.99 240
2025 Q2 35.7M $1.06B -$27.7M $29.57 221
2025 Q1 36.8M $1.1B -$11.5M $29.85 241
2024 Q4 37.1M $1.06B -$54.5M $28.65 238
2024 Q3 38.5M $1.49B -$25.8M $38.64 248
2024 Q2 39.7M $1.28B -$10.1M $32.20 229
2024 Q1 39.6M $1.54B +$15.8M $38.82 226
2023 Q4 39.2M $1.21B +$15.9M $30.78 190
2023 Q3 38.7M $865M -$10.1M $22.35 174
2023 Q2 39.2M $843M +$2.46M $21.49 177
2023 Q1 39M $937M +$74.1M $23.99 196
2022 Q4 36.1M $837M +$6.54M $23.20 174
2022 Q3 35.9M $575M -$19.5M $16.02 158
2022 Q2 36.4M $646M +$14.2M $17.72 152
2022 Q1 36.1M $734M +$6.78M $20.36 161
2021 Q4 35.8M $669M -$13.9M $18.68 152
2021 Q3 36.4M $719M -$39.4M $19.74 150
2021 Q2 38M $898M -$27.3K $23.64 155
2021 Q1 38M $901M +$32.1M $23.70 161
2020 Q4 37.1M $744M -$8.93M $20.03 135
2020 Q3 39M $812M +$4.16M $20.82 140
2020 Q2 37M $648M +$3.97M $17.50 149
2020 Q1 36.9M $603M +$85M $16.33 157
2019 Q4 31.5M $649M +$50.7M $20.58 134
2019 Q3 30M $345M -$4.71M $11.48 116
2019 Q2 30.8M $405M -$9.46M $13.15 127
2019 Q1 31.4M $476M -$37.4M $15.14 142
2018 Q4 33.8M $579M +$15.8M $17.17 119
2018 Q3 33.5M $492M +$14.7M $14.74 122
2018 Q2 31M $740M +$15.8M $23.85 131
2018 Q1 30.3M $773M +$49.3M $25.55 135
2017 Q4 28.5M $526M +$70.7M $18.46 99
2017 Q3 26M $273M +$14.1M $10.49 74
2017 Q2 24.5M $307M +$19.6M $12.51 69
2017 Q1 23.4M $235M +$9.4M $10.06 80
2016 Q4 23.3M $363M +$116M $15.57 86
2016 Q3 15.9M $306M +$28.9M $19.26 71
2016 Q2 14.6M $173M -$11.5M $11.85 73
2016 Q1 14.9M $270M +$54.4M $18.15 70
2015 Q4 11.9M $327M -$5.74M $27.50 58
2015 Q3 10.2M $227M +$24.6M $22.11 45
2015 Q2 9.28M $165M +$165M $17.84 45